Dietary guidelines for saturated fatty acids are not supported by the evidence

International Dairy Journal

Volumn 52, Issue , 2016, Pages 115-123

  Parodi, Peter W ^a  

^a Human Nutrition and Health Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATES; CHOLESTEROL; POLYUNSATURATED FATTY ACIDS;

COMMUNITY-BASED; CONTROLLED TRIAL; CORONARY HEART DISEASE; DIETARY GUIDELINES; EDUCATION PROGRAMS; HDL CHOLESTEROLS; LDL CHOLESTEROL; TRIGLYCERIDE LEVELS;

SATURATED FATTY ACIDS;

EID: 84946541730     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2015.08.007     Document Type: Review

References (102)

1. Ascherio A., Rimm E.B., Giovannucci E.L., Spiegelman D., Stampfer M., Willett W.C. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. British Medical Journal 1996, 313:84-90.
2. Asztalos B.F., Tani M., Schaefer E.J. Metabolic and functional relevance of HDL subspecies. Current Opinion in Lipidology 2011, 22:176-185.
3. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J.P., Komajda M., et al. Effects of torcetrapib in patients at high risk for coronary events. New England Journal of Medicine 2007, 357:2109-2122.
4. Bergmark C., Dewan A., Orsomi A., Merki E., Miller E.R., Shin M.-J., et al. A novel function of lipoprotein[a] as a preferential carrier of oxidized phospholipids in human plasma. Journal of Lipid Research 2008, 49:2230-2239.
5. Bucher H.C., Griffith L.E., Guyatt G.H. Systematic review of the risk and benefit of different cholesterol-lowering interventions. Arteriosclerosis Thrombosis and Vascular Biology 1999, 19:187-195.
6. Carleton R.A., Lasater T.M., Assaf A.R., Feldman H.A., McKinlay S. The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. American Journal of Public Health 1995, 85:777-785.
7. Chapman M.J., Redfern J.S., McGovern M.E., Giral P. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Pharmacology and Therapeutics 2010, 126:314-345.
8. Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
9. Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., et al. Association of dietary, circulating and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of Internal Medicine 2014, 160:398-406.
10. Clarke R., Frost C., Collins R., Appleby P., Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. British Medical Journal 1997, 314:112-117.
11. Cooper G.R., Myers G.L., Smith S.J., Schlant R.C. Blood lipid measurements. Journal of the American Medical Association 1992, 67:1652-1660.
12. Davey Smith G., Song F., Sheldon T.A. Cholesterol lowering and mortality: the importance of considering initial level of risk. British Medical Journal 1993, 306:1367-1373.
13. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004, 109(Suppl. III):39-43.
14. Denke M.A. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. American Journal of Clinical Nutrition 1995, 62:471S-477S.
15. Denke M.A. Cholesterol-lowering diets. Archives of Internal Medicine 1995, 155:17-26.
16. Dimsdale J.E., Herd J.A. Variability of plasma lipids in response to emotional arousal. Psychosomatic Medicine 1982, 44:413-430.
17. Dreon D.M., Fernstrom H.A., Campos H., Blanche P., Williams P.T., Krauss R.M. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. American Journal of Clinical Nutrition 1998, 67:828-836.
18. Drew B.G., Rye K.A., Duffy S.J., Barter P., Kingwell B.A. The emerging role of HDL in glucose metabolism. National Review of Endocrinology 2012, 8:237-245.
19. Ebrahim S., Davey Smith G. Exporting failure? Coronary heart disease and stroke in developing countries. International Journal of Epidemiology 2001, 30:201-205.
20. Emerging Risk Factors Collaboration Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Journal of the American Medical Association 2009, 302:412-423.
21. Faghihnia N., Tsimikas S., Miller E.R., Witztum J.L., Krauss R.M. Changes in lipoprotein(a), oxidized phospholipids, and LDL classes with a low-fat high-carbohydrate diet. Journal of Lipid Research 2010, 51:3324-3330.
22. Feig J.E., Hewing B., Smith J.D., Hazen S.L., Fisher E.A. High-density lipoprotein and atherosclerosis regression. Circulation Research 2014, 114:205-213.
23. Forsythe C.E., Phinney S.D., Feinman R.D., Volk B.M., Freidenreich D., Quann E., et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010, 45:947-962.
24. Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Dibus D.M., et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43:65-77.
25. Fortmann S.P., Varady A.N. Effects of a community-wide education program on cardiovascular disease morbidity and mortality. American Journal Epidemiology 2000, 152:316-323.
26. Frideman M., Rosenman R.H., Carroll V. Changes in serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation 1958, 17:852-861.
27. Ginsberg H.N., Barr S., Gilbert A., Karmally W., Deckelbaum R., Kaplan K., et al. Reduction of plasma cholesterol levels in normal men on an American Heart Association step 1 diet with added monounsaturated fat. New England Journal of Medicine 1990, 322:574-579.
28. Ginsburg G.S., Safran C., Pasternak R.C. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels. American Journal of Cardiology 1991, 68:187-192.
29. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. Predicting coronary heart disease in middle-aged and older persons. The Framington study. Journal of the American Medical Association 1977, 238:497-499.
30. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989, 79:8-15.
31. Grundy S.M., Vega G.L. Causes of high blood cholesterol. Circulation 1990, 81:412-427.
32. Hooper L., Martin N., Abdelhamid A., Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews Issue 2015, 6. No.: CD011737.
33. Howard B.V., Van Horn L., Hsia J., Manson J.E., Stefanick M.L., Wassertheil-Smoller S., et al. Low fat dietary pattern and risk of cardiovascular disease. Journal of the American Medical Association 2006, 295:655-666.
34. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., et al. Dietary fat intake and the risk of coronary heart disease in women. New England Journal of Medicine 1997, 337:1491-1499.
35. IOM Evaluation of biomarkers and surrogate endpoints in chronic disease 2010, Institute of Medicine, The National Academies Press, Washington, DC, USA.
36. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., Pereira M.A., Bälter K., Fraser G.E., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. American Journal of Clinical Nutrition 2009, 89:1425-1432.
37. Kahn H.A., Medalie J.H., Neufeld H.N., Riss E., Balogh M., Groen J.J. Serum Cholesterol: Its distribution and association with dietary and other variables in a survey of 10,000 men. Israel Journal of Medical Science 1969, 5:1117-1137.
38. Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerosis. Annals of Internal Medicine 1979, 90:85-91.
39. Kannel W.B., Gordon T. The Framingham Study. An epidemiological investigation of cardiovascular diseases. The Framingham diet study: Diet and the regulation of serum cholesterol (Section 24) 1970, US Government Printing Office, Washington, DC, USA.
40. Kathiresan S., Larson M.G., Vasan R.S., Guo C.Y., Gona P., Keaney J.F., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006, 113:1415-1423.
41. Keene D., Price C., Shun-Shin M.J., Francis D.P. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. British Medical Journal 2014, 349:g4379.
42. Keys A., Anderson J.T., Grande F. Serum cholesterol in man: dietary fat and intrinsic responsiveness. Circulation 1959, 19:201-214.
43. King I.B., Lemaitre R.N., Kestin M. Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. American Journal Clinical Nutrition 2006, 83:227-236.
44. Kingwell B.A., Chapman M.J. Future of high-density lipoprotein infusion therapies. Circulation 2013, 128:1112-1121.
45. Kingwell B.A., Chapman M.J., Kontush A., Miller N.E. HDL-targeted therapies: progress, failures and future. Nature Reviews Drug Discovery 2014, 13:445-464.
46. Kontush A., Chapman M.J. Antiatherogenic small, dense HDL - guardian angel of the arterial wall?. Nature Clinical Practice Cardiovascular Medicine 2006, 3:144-153.
47. Krauss R.M. Dietary and genetic probes of atherogenic dyslipidemia. Arteriosclerosis Thrombosis and Vascular Biology 2005, 25:2265-2272.
48. Krauss R.M., Blanche P.J., Rawlings R.S., Fernstrom H.S., Williams P.T. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. American Journal of Clinical Nutrition 2006, 83:1025-1031.
49. Krauss R.M., Burke D.J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. Journal of Lipid Research 1982, 23:97-104.
50. Lemieux I., Lamarche B., Couillard C., Pascot A., Cantin B., Bergeron J., et al. Total cholesterol/HDL ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischaemic heart disease risk in men. Archives in Internal Medicine 2001, 161:2685-2692.
51. Luepker R.V., Rastam L., Hannan P.J., Murray D.M., Gray C., Baker W.L., et al. Community education for cardiovascular disease prevention. American Journal of Epidemiology 1996, 144:351-362.
52. Maron D.J., Fazio S., Linton M.F. Current perspectives on statins. Circulation 2000, 101:207-213.
53. Martin M.J., Hulley S.B., Browner W.S., Kuller L.H., Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet, I 1986, 933-936.
54. Mensink R.P., Zock P.L., Kester A.D.M., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition 2003, 77:1146-1155.
55. Miettinen M., Turpeinen O., Karvonen M.J., Pekkarinen M., Paavilainen E., Elosuo R., et al. Dietary prevention of coronary heart disease in women: the Finnish Mental Hospital Study. International Journal of Epidemiology 1983, 12:17-25.
56. Miller N.E. CETP inhibitors and cardiovascular disease: Time to think again 2014, 124. F1000Research, 3.
57. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomised controlled trials. PLoS Medicine 2010, 7:e1000252.
58. Multiple Risk Factor Intervention Trial Research Group Multiple risk factor intervention trial. Journal of the American Medical Association 1982, 248:1465-1477.
59. Murphy A.J., Funt S., Gorman D., Tall A.R., Wang N. Pegylation of high-density lipoprotein decreases plasma clearance and enhances atherogenic activity. Circulation Research 2013, 113:e1-e9.
60. Nichols A.B., Ravenscroft C., Lamphiear D.E., Ostrander L.D. Daily nutritional intake and serum lipid levels. The Tecumseh study. American Journal of Clinical Nutrition 1976, 29:1384-1392.
61. Nordestgaard B.G., Chapman M.J., Ray K., Boren J., Andreotti F., Watts G.F., et al. Lipoprotein(a) as a cardiovascular risk factor: current status. European Heart Journal 2010, 31:2844-2853.
62. Oh K., Hu F.B., Manson J.E., Stampfer M.J., Willett W.C. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. American Journal of Epidemiology 2005, 161:672-679.
63. Parodi P.W. Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?. International Dairy Journal 2009, 19:345-361.
64. Pekkanen J., Linn S., Heiss G., Suchindran C.M., Leon A., Rifkind B.M., et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without pre-existing cardiovascular disease. New England Journal of Medicine 1990, 322:1700-1707.
65. Petersen K.F., Dufor S., Savage D.B., Bilz S., Solomon G., Yonemitsu S., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. PNAS 2007, 104:12587-12594.
66. Pietinen P., Ascherio A., Korhonen P., Hartman A.M., Willett W.C., Albanes D., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. American Journal of Epidemiology 1997, 145:876-887.
67. Prospective Studies Collaboration Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
68. Ramsden C.E., Hibbeln J.R., Majchrzak S.F., Davis J.M. n-6 Fatty acid specific and mixed polyunsaturated dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. British Journal of Nutrition 2010, 104:1586-1600.
69. Ramsden C.E., Zamora D., Leelarthaepin B., Majchrzak-Hong S.F., Faurot K.R., Suchindran C.M., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Heart Study and updated meta-analysis. British Medical Journal 2013, 346:e8707.
70. Reaven G.M., Chen Y.D., Jeppesen J., Maheux P., Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. Journal of Clinical Investigation 1993, 92:141-146.
71. Reilly J.G., Ayis S.A., Ferrier I.N., Jones S.J., Thomas S.H.L. Thioridazine and sudden unexplained death in psychiatric in-patients. British Journal of Psychiatry 2002, 180:515-522.
72. Ridker P.M., Danielson E., Fonseca F.A.H., Genest J., Gotto A.M., Kastelein J.P.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 2008, 358:2195-2207.
73. Rosenson R.S., Brewer H.B., Ansell B., Barter P., Chapman M.J., Heinecke J.W., et al. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation 2013, 128:1256-1267.
74. Rye K.-A., Buirsill C.A., Lambert G., Tabert F., Barter P.J. The metabolism and anti-atherogenic properties of HDL. Journal of Lipid Research 2009, 50:S195-S200.
75. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine 1996, 335:1001-1009.
76. Salonen J.T. Did the North Karelia project reduce coronary mortality?. Lancet 1987, 2:269.
77. Schwartz G.G., Olsson A.G., Abt M., Ballantyne C.M., Barter P.J., Brumm J., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England Journal of Medicine 2012, 367:2089-2099.
78. Schwarz J.-M., Linfoot P., Dare D., Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. American Journal of Clinical Nutrition 2003, 77:43-50.
79. Shephard J., Cobbe S.M., Ford I., Isles G., Lorimer A.R., Macfarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 1995, 333:1301-1307.
80. Singh I.M., Shishehbor M.H., Ansell B.J. High-density lipoprotein as a therapeutic target. Journal of the American Medical Association 2007, 298:786-798.
81. Siri-Tarino P.W., Sun Q., Hu F.B., Krause R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition 2010, 91:535-546.
82. Skeaff M.C., Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Nutrition and Metabolism 2009, 55:173-201.
83. Sniderman A.D., Silberberg J. Is it time to measure apolipoprotein B?. Arteriosclerosis 1990, 10:665-667.
84. Strawford A., Antelo F., Christiansen M., Hellerstein M.K. Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. American Journal of Physiology Endocrinology and Metabolism 2004, 286:E577-E588.
85. Studer M., Briel M., Leimenstoll B., Glass T.R., Bucher H.C. Effect of different antilipidemic agents and diets on mortality. Archives of Internal Medicine 2005, 165:725-730.
86. Stulb S.C., McDonough J.R., Greenberg B.G., Hames C.G. The relationship of nutrient intake and exercise to serum cholesterol levels in white males in Evans County, Georgia. American Journal of Clinical Nutrition 1965, 16:238-242.
87. Superko H.R., Gadesam R.R. Is it LDL particle size or number that correlates with risk for cardiovascular disease?. Current Atherosclerosis Reports 2008, 10:377-385.
88. Talayero B.G., Sacks F.M. The role of triglycerides in atherosclerosis. Current Cardiology Reports 2011, 13:544-552.
89. Tang J.L., Armitage J.M., Lancaster T., Silagy C.A., Fowler G.H., Neil H.A. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. British Medical Journal 1998, 318:1213-1220.
90. Tuomilehto J., Geboers J., Salonen J.T., Nissinen A., Kuulasmaa K., Puska P. Decline in cardiovascular mortality in North Karelia and other parts of Finland. British Medical Journal (Clinical Research Education) 1986, 293:1068-1071.
91. Turpeinen O., Karvonen M.J., Pekkarinen M., Miettinen M., Elosuo R., Paavilainen E. Dietary prevention of coronary heart disease: The Finnish Mental Hospital Study. International Journal of Epidemiology 1979, 8:99-118.
92. US Department of Agriculture, Department of Health and Human Services Report of the Dietary Guidelines Advisory Committee on the dietary guidelines for Americans 2010, US Department of Agriculture, Washington, DC, USA.
93. Vergeer M., Holleboom A.G., Kastelein J.J.P., Kuivenhoven J.A. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis. Journal of Lipid Research 2012, 51:2058-2073.
94. Verschuren W.M.M., Jacobs D.R., Bloemberg B.P.M., Kromhout D., Menotti A., Aravanis C., et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Journal of the American Medical Association 1995, 274:131-136.
95. Volk B.M., Kunces L.J., Freidenreich D.J., Kupchak B.R., Saenz C., Artistizabal J.C., et al. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS ONE 2014, 9:e113605. 10.1371/jornal.pone.0113605.
96. Wallstrom P., Sonestedt E., Hlebowicz J., Ericson U., Drake I., Persson M. Dietary fiber and saturated fat intake associations with cardiovascular disease differ by sex in the Malmo Diet and Cancer Cohort; a prospective study. PLoS ONE 2012, 7:e31637. 10.1371/journal.pone.003163722.
97. Winkleby M.A., Feldman H.A., Murray D.M. Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. Journal of Clinical Epidemiology 1997, 50:645-658.
98. Woodhill J.M., Palmer A.J., Leelarthaepin B., McGilchrist C., Blacket R.B. Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology 1978, 109:317-330.
99. Woollett L.A., Spady D.K., Dietschy J.M. Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. Journal of Clinical Investigation 1992, 89:1133-1141.
100. Yamagishi K., Iso H., Yatsuya H., Tanabe N., Date C., Kikuchi S., et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. American Journal of Clinical Nutrition 2010, 92:759-765.
101. Ye S.Q., Kwiterovich P.O. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. American Journal of Clinical Nutrition 2000, 72:1275S-1284S.
102. Zhou Q., Liao K. Pleiotropic effects of statins. Circulation Journal 2010, 74:818-826.